Variant report
Variant | esv3342339 |
---|---|
Chromosome Location | chr16:64835101-64838799 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111745149 | chr16:64836410-64836411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565594126 | chr16:64836490-64836491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527847691 | chr16:64836500-64836501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188281930 | chr16:64836511-64836512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144293916 | chr16:64836526-64836527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541213792 | chr16:64836587-64836588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561176142 | chr16:64836618-64836619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568059574 | chr16:64836652-64836653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62040424 | chr16:64836662-64836663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559120872 | chr16:64836709-64836710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201423620 | chr16:64836723-64836724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549855081 | chr16:64836785-64836786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374054250 | chr16:64836789-64836790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569501388 | chr16:64836899-64836900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532152755 | chr16:64837014-64837015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79357625 | chr16:64837024-64837025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565964122 | chr16:64837104-64837105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79693125 | chr16:64837253-64837254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554800590 | chr16:64837275-64837276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568300685 | chr16:64837303-64837304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs193187170 | chr16:64837341-64837342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536308964 | chr16:64837344-64837345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535173095 | chr16:64837424-64837425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576329885 | chr16:64837444-64837445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545401089 | chr16:64837445-64837446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150432963 | chr16:64837451-64837452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113713350 | chr16:64837484-64837485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541373771 | chr16:64837493-64837494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368274971 | chr16:64837504-64837505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561139158 | chr16:64837511-64837512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370538709 | chr16:64837512-64837513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376652256 | chr16:64837513-64837514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200766298 | chr16:64837515-64837516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530317161 | chr16:64837542-64837543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543121433 | chr16:64837587-64837588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138125985 | chr16:64837606-64837607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs72788797 | chr16:64837619-64837620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552127509 | chr16:64837637-64837638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559436211 | chr16:64837715-64837716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563084643 | chr16:64837716-64837717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185221992 | chr16:64837764-64837765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548514417 | chr16:64837787-64837788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79460095 | chr16:64837835-64837836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537272750 | chr16:64837928-64837929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549973033 | chr16:64837942-64837943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570122540 | chr16:64837986-64837987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538788497 | chr16:64838041-64838042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535712228 | chr16:64838054-64838055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556029745 | chr16:64838086-64838087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558527474 | chr16:64838120-64838121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Infertility | 21528002 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 20409316 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Leiomyosarcoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:64836400-64837200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr16:64837200-64842200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr16:64837600-64838000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |